Schedule 13D ownership disclosure

REGENERX BIOPHARMACEUTICALS CO

Security class unavailable · CUSIP: 75886X108

Event date: 2015-02-01

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
19,583,333
Percent of class
19.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001596770-15-000032
Form type
SC 13D/A
Filer
G-treeBNT Co., Ltd.
CIK
CIK 1602801
Filed
Apr 01, 2015
Reporting period
Feb 01, 2015
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub